Sign in

Research summary ·

Efficacy and safety of selective orexin 2 receptor agonists in narcolepsy type 1: a systematic review and meta-analysis of randomized controlled trials.

Written based on 1 research study on PubMed, searched on 14 Nov 2026.

What was studied

This study pooled results from earlier trials of a group of drugs. The drugs switch on a target called the orexin 2 receptor. They were tested in people with narcolepsy type 1. The team searched research databases up to September 2026. They kept only trials where people got the drug or a dummy pill. Neither people nor doctors knew who got which. The drugs were taken by mouth.

What they found

The trials included 550 people in total. They tested TAK-994, oveporexton, or alixorexton for 6-12 weeks. The main results came from 337 people. Compared with the dummy pill, people stayed awake longer in a lab test. On average, they stayed awake 22.7 minutes longer. They scored 9.8 points lower on a sleepiness scale. Weekly cataplexy attacks also became less frequent. More people on the drugs had to pass urine often or urgently. They also had more trouble sleeping and more saliva. Work on TAK-994 was stopped after it harmed the liver.

What it means for patients

Over a short time, these drugs helped people stay awake. They also eased sleepiness and cataplexy attacks. Some side effects were more common with the drugs. Liver harm ended work on one of the drugs.

Why it is not certain yet

Only a few trials were found. The trials lasted only 6-12 weeks. So long-term safety is still not known. Results for the awake test varied a lot between trials. The certainty for that result was rated low. It is unclear if all drugs in this group act alike. A review can only be as good as the studies in it.

Source

Efficacy and safety of selective orexin 2 receptor agonists in narcolepsy type 1: a systematic review and meta-analysis of randomized controlled trials.

PubMed · PMID 43012908

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Narcolepsy publications